News

Structural Transition, Function and Dysfunction of TDP-43 in Neurodegenerative Diseases.

Afroz T, Pérez-Berlanga M, Polymenidou M. Chimia (Aarau). 2019 May 29;73(6):380-390.

01 Juni 2019


Rescue of spinal muscular atrophy mouse models with AAV9-Exon-specific U1 snRNA.

Donadon I, Bussani E, Riccardi F, Licastro D, Romano G, Pianigiani G, Pinotti M, Kostantinova P, Evers M, Lin S, Rüegg MA, Pagani F. Nucleic Acids Res. 2019 May 25....

31 Mai 2019


Aging Disrupts Muscle Stem Cell Function by Impairing Matricellular WISP1 Secretion from Fibro-Adipogenic Progenitors.

Lukjanenko L, Karaz S, Stuelsatz P, Gurriaran-Rodriguez U, Michaud J, Dammone G, Sizzano F, Mashinchian O, Ancel S, Migliavacca E, Liot S, Jacot G, Metairon S, Raymond...

30 Mai 2019


Extraocular muscle function is impaired in ryr3 -/- mice.

Eckhardt J, Bachmann C, Sekulic-Jablanovic M, Enzmann V, Park KH, Ma J, Takeshima H, Zorzato F, Treves S. J Gen Physiol. 2019 May 13

20 Mai 2019


Specific inhibition of splicing factor activity by decoy RNA oligonucleotides.

Denichenko P, Mogilevsky M, Cléry A, Welte T, Biran J, Shimshon O, Barnabas GD, Danan-Gotthold M, Kumar S, Yavin E, Levanon EY, Allain FH, Geiger T, Levkowitz G, Karni...

17 Mai 2019


Pharmacological targeting of age-related changes in skeletal muscle tissue.

Leuchtmann AB, Handschin C. Pharmacol Res. 2019 Mar 4. pii: S1043-6618(18)31953-4.

02 Mai 2019


Exploration of New Contrasts, Targets, and MR Imaging and Spectroscopy Techniques for Neuromuscular Disease - A Workshop Report of Working Group 3 of the Biomedicine and Molecular Biosciences COST Action BM1304 MYO-MRI.

Strijkers GJ, Araujo ECA, Azzabou N, Bendahan D, Blamire A, Burakiewicz J, Carlier PG, Damon B, Deligianni X, Froeling M, Heerschap A, Hollingsworth KG, Hooijmans MT,...

01 Mai 2019


Aberrant regulation of epigenetic modifiers contributes to the pathogenesis in patients with selenoprotein N-related myopathies.

Bachmann C, Noreen F, Voermans NC, Schär PL, Vissing J, Fock JM, Bulk S, Kusters B, Moore SA, Beggs AH, Mathews KD, Meyer M, Genetti CA, Meola G, Cardani R, Mathews E,...

16 April 2019


Polyneuron raises CHF 22.5 Million in series A to advance novel therapies for autoimmune diseases

"The proceeds will be used to perform a first-in-human trial with the company’s lead product, PN-1007, a potential treatment for anti-MAG neuropathy, a rare nervous...

28 März 2019


<< Erste < Vorherige 1-10 11-20 21-30 31-40 41-50 51-60 61-70 Nächste > Letzte >>